Orgenesis Inc (ORGS) - Total Liabilities
Based on the latest financial reports, Orgenesis Inc (ORGS) has total liabilities worth $53.62 Million USD as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Orgenesis Inc annual equity growth to track the company's year-over-year net asset growth rate.
Orgenesis Inc - Total Liabilities Trend (2008–2023)
This chart illustrates how Orgenesis Inc's total liabilities have evolved over time, based on quarterly financial data. See ORGS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Orgenesis Inc Competitors by Total Liabilities
The table below lists competitors of Orgenesis Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Middle Island Resources Ltd
AU:MDI
|
Australia | AU$177.43K |
|
Acceleware Ltd
V:AXE
|
Canada | CA$6.75 Million |
|
Opus One Resources Inc
V:OOR
|
Canada | CA$1.33 Million |
|
SKY E&M Co. Ltd
KQ:131100
|
Korea | ₩25.99 Billion |
|
Hammer Metals Limited
F:6HM
|
Germany | €1.02 Million |
|
Akora Resources Ltd
AU:AKO
|
Australia | AU$296.45K |
|
Medicure Inc
V:MPH
|
Canada | CA$10.73 Million |
|
Edinburgh Worldwide Investment Trust plc
LSE:EWI
|
UK | GBX57.63 Million |
Liability Composition Analysis (2008–2023)
This chart breaks down Orgenesis Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Orgenesis Inc (ORGS) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Orgenesis Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Orgenesis Inc (2008–2023)
The table below shows the annual total liabilities of Orgenesis Inc from 2008 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $35.53 Million | +12.26% |
| 2022-12-31 | $31.65 Million | +49.24% |
| 2021-12-31 | $21.21 Million | -15.01% |
| 2020-12-31 | $24.96 Million | -71.12% |
| 2019-12-31 | $86.42 Million | +84.66% |
| 2018-12-31 | $46.80 Million | 0.00% |
| 2018-11-30 | $46.80 Million | +81.75% |
| 2017-12-31 | $25.75 Million | +12.40% |
| 2016-12-31 | $22.91 Million | -49.30% |
| 2015-12-31 | $45.19 Million | +764.30% |
| 2014-12-31 | $5.23 Million | +143.33% |
| 2013-12-31 | $2.15 Million | +553.63% |
| 2012-12-31 | $328.72K | +286.67% |
| 2011-12-31 | $85.01K | +612.12% |
| 2010-12-31 | $11.94K | +98.97% |
| 2009-12-31 | $6.00K | +71.43% |
| 2008-12-31 | $3.50K | -- |
About Orgenesis Inc
Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of res… Read more